管理
• 文章

From pioneer to expert: Dr CS Ho’s journey in the evolution of clinical mass spectrometry

Dr Chung Shun “CS” Ho, pioneer in mass spectrometry, gives an overview of how the technology and its associated tools have evolved from his 1995 debut. In this episode of Leaders in Conversation with Ronald Lo, General Manager of Roche Diagnostics Hong Kong, Dr Ho recounts how mass spectrometry started from a niche discipline to the evolved, integrated machinery it is today. When he first started at The Chinese University of Hong Kong, Dr Ho has been at the helm of working with mass spectrometry since its introduction to the university. Years of experimenting with it has led to discoveries in better testing techniques, analysis with upgraded accompanying software, and laboratory workflows. Improving skills in mass spectrometry is only one part of it, Dr Ho also enjoys that community of like-minded researchers and professionals he has encountered in this journey of clinical mass spectrometry.
Star

阅读列表

所有类别
  • 所有类别
  • 疾病领域
  • 事件报道
  • 管理
  • 运营
疾病领域
• 文章

Why early CSF testing is a game-changer for Alzheimer’s disease in China

疾病领域
• 文章

Beyond the bite: why blood transfusion safety matters amidst the global dengue surge

运营
• 文章

Co-creating change beyond the machine: why effective total lab automation starts with its people

疾病领域
• 文章

Why expanding access to accurate dengue tests is a critical need in Asia

ProjectorScreen

热门阅读

hcv
疾病领域
• 文章
The practical benefits of HCV antigen-antibody dual assay: Q&A with Prof Tawesak Tanwandee
Bridging the quality gap in digital pathology from pre analytics to AI QA with Dr Kunal Sharma
管理
• 文章
AI as the essential co-pilot for modern digital pathology: Q&A with Dr Kunal Sharma
事件报道
• 文章
国际乳头状瘤病毒学会 (IPVS 2025) 第 37 届年会的要点速览
事件报道
• 文章
数字化给药与治疗药物监测的未来：第 23 届 IATDMCT 大会洞见

医疗保健社区

关于撰稿人的更多信息>

医疗保健社区

关于撰稿人的更多信息>
筛选器

关于撰稿人的更多信息>
Scroll to Top